Table: Aska Pharmaceutical Holdings -Q1 group results

ASKA Pharmaceutical Holdings

05/08/2024 07:01

Aug 5 (Reuters)- 
             Aska Pharmaceutical Holdings Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             16.35               16.02            63.00    
                 (+2.1 pct)          (+4.9 pct)       (+0.2 pct)  
  Operating          1.76                1.70             6.70    
                 (+3.1 pct)          (+2.4 pct)       (+3.1 pct)  
  Recurring          1.81                1.81             6.70    
                 (+0.2 pct)          (+0.2 pct)       (+2.7 pct)  
  Net                1.27                1.43             5.00    
                 (-10.9 pct)         (+8.0 pct)       (-33.7 pct) 
  EPS             44.95 yen           50.51 yen       176.50 yen  
  Ann Div                             40.00 yen        50.00 yen  
  -Q2 div                             20.00 yen        25.00 yen  
  -Q4 div                             20.00 yen        25.00 yen  
  
  NOTE - Aska Pharmaceutical Holdings Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T